PAVmed Inc. Common Stock (PAVM)
Stock · NASDAQ · Health Care
$4.92as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Resistance level
$9.02
Industry
Medical/Dental Instruments
Fundamentals
- Market cap
- $35.93M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How PAVmed Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 27, 2026 · via SEC EDGAR / Finnhub
PAVmed Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PAVMPAVmed Inc. Common Stock$4.92▼ 2.96%Market cap $35.93MP/E —
- ARAYAccuray Incorporated Common Stock$0.2772▲ 6.62%Market cap $33.63MP/E —$0.22$2.1
- TELATELA Bio Inc. Common Stock$0.6748▲ 3.82%Market cap $38.50MP/E —$0.5011$1.91
- NEPHNephros Inc. Common Stock$4.61▲ 6.96%Market cap $38.98MP/E 64.38$2.66$6.42
- BEATHeartbeam Inc. Common Stock$0.4693▼ 3.44%Market cap $28.33MP/E —$0.471$4
- CTSOCytosorbents Corporation Common Stock$0.336▼ 3.34%Market cap $25.05MP/E —$0.3$1.04
- SRTSSensus Healthcare Inc. Common Stock$3.56▲ 5.64%Market cap $49.06MP/E —$2.66$5.49
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PAVM PAVmed Inc. Common Stock | $35.93M | — | $4.92 | ▼ 2.96% | |
| ARAY Accuray Incorporated Common Stock | $33.63M | — | $0.2772 | ▲ 6.62% | $0.22$2.1 |
| TELA TELA Bio Inc. Common Stock | $38.50M | — | $0.6748 | ▲ 3.82% | $0.5011$1.91 |
| NEPH Nephros Inc. Common Stock | $38.98M | 64.38 | $4.61 | ▲ 6.96% | $2.66$6.42 |
| BEAT Heartbeam Inc. Common Stock | $28.33M | — | $0.4693 | ▼ 3.44% | $0.471$4 |
| CTSO Cytosorbents Corporation Common Stock | $25.05M | — | $0.336 | ▼ 3.34% | $0.3$1.04 |
| SRTS Sensus Healthcare Inc. Common Stock | $49.06M | — | $3.56 | ▲ 5.64% | $2.66$5.49 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- PAVmed Inc. (PAVM) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/14/2026
- PAVmed Q2 2026 Earnings Call: Complete TranscriptBenzinga · 8/14/2026
- PAVmed Q2 Adj. EPS $(0.27) Beats $(0.58) Estimate, Sales $33.000K Miss $72.000K EstimateBenzinga · 8/14/2026
Insider Activity
Insider Actions →Acquired
889.6K
Disposed
0
- Victoria Tou-ho Lee · April 2, 2026 · Grant70.0K
- Lishan Aklog · April 2, 2026 · Grant350.0K
- Michael J. Glennon · April 2, 2026 · Grant13.9K
- Timothy E. Baxter · April 2, 2026 · Grant13.9K
- Debra White · April 2, 2026 · Grant13.9K
- Ronald M. Sparks · April 2, 2026 · Grant13.9K
- Sundeep Agrawal · April 2, 2026 · Grant13.9K
- Michael Adam Gordon · April 2, 2026 · Grant110.0K
- Shaun O'Neil · April 2, 2026 · Grant110.0K
- Dennis M. McGrath · April 2, 2026 · Grant180.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 506.6K
- Total value held
- $5.14M
- Institutional holders
- 18
Top holders this quarter
- Unknown461.5K
- Unknown23.8K
- Unknown11.8K
- Unknown5.9K
- Unknown2.4K
- Unknown622
- Unknown165
- Unknown157
- Unknown75
- Unknown67
See the full, filterable feed with live charts on the MarketWall dashboard.